Fertility after intrauterine device removal: a pilot study

The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
Amy M StoddardJeffrey F Peipert

Abstract

Despite high efficacy, only 7.7% of women in the United States currently using contraception use an IUD. There is little published contemporary data about fertility rates after IUD use, especially in nulliparous women and women using the hormonal IUD. We recruited sexually active women 18 to 35 years of age enrolled in the Contraceptive CHOICE Project who had discontinued a contraceptive method and desired pregnancy. In this pilot project, we enrolled 69 former IUD users (19 copper and 50 levonorgestrel) and 42 former non-IUD users. Pregnancy rates at 12 months were similar between the two groups; 81% of IUD users became pregnant compared to 70% of non-IUD users (p = 0.18). In the Cox model, there was no difference in the time to pregnancy in IUD users compared to non-IUD users (HRadj 1.19, 95% CI 0.74-1.92). African American race was the only variable associated with reduced fertility (HRadj 0.40, 95% CI 0.24-0.67). We found no difference in 12-month pregnancy rates or time to pregnancy between former IUD users and users of other contraceptive methods. However, there was a clinically and statistically significant reduction in fertility in African American women.

References

Jun 1, 1986·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·L AndolsekM J Rosenberg
Sep 1, 1988·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·F Skjeldestad, H Bratt
Apr 11, 1985·The New England Journal of Medicine·J R DalingB V Stadel
Apr 11, 1985·The New England Journal of Medicine·D W CramerB V Stadel
Sep 1, 1985·Contraception·L RandicC S Waszak
Jan 8, 1983·British Medical Journal·M P VesseyD Yeates
Sep 1, 2001·The New England Journal of Medicine·D HubacherR Guzmán-Rodríguez
Jun 4, 2002·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·W DelbargeD Wildemeersch
Sep 6, 2006·Fertility and Sterility·Elizabeth Hervey Stephen, Anjani Chandra
Jun 15, 2010·American Journal of Obstetrics and Gynecology·Gina M SecuraJeffrey F Peipert
Dec 22, 2010·Obstetrics and Gynecology·Katherine J HladkyJeffrey F Peipert
Mar 22, 2012·Obstetrics and Gynecology·Crystal P TylerPolly A Marchbanks
May 25, 2012·The New England Journal of Medicine·Brooke WinnerGina M Secura
Jul 17, 2012·Fertility and Sterility·Lawrence B FinerMegan L Kavanaugh

❮ Previous
Next ❯

Citations

Apr 2, 2016·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Amanda BlackShireen Mansouri
May 29, 2016·The Medical Clinics of North America·Caitlin AllenEliza L Sutton
Feb 2, 2017·The New England Journal of Medicine·Kathryn M Curtis, Jeffrey F Peipert
May 27, 2020·Clinical Obstetrics and Gynecology·Yasmin Z Bahar, Melanie A Gold
Jul 9, 2020·Journal of Clinical Medicine·Magdalena ZgliczynskaKatarzyna Kosinska-Kaczynska
Nov 13, 2020·BMJ : British Medical Journal·Jennifer J YlandLauren A Wise
Mar 16, 2021·American Journal of Obstetrics and Gynecology·Jeffrey F PeipertJoanne Daggy
Oct 15, 2021·Médecine sciences : M/S·Lise Duranteau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.